IP Library Granted Patent US 12699087
Granted Patent B2
US 12699087 · App. 18/021,945 · Granted Aug 4, 2026

Monitoring of in vitro protein synthesis

Inventors: Michael Chun Hao Chen (Cambridge, GB); Sihong Chen (Cambridge, GB); Stephanie Reikine (Cambridge, GB); Richard J. Paolini, Jr. (Billerica, MA); Luke Slominski (Billerica, MA); Sumit Kalsi (Cambridge, GB); Atanas Yordanov Georgiev (Cambridge, MA); Chiara Gandini (Cambridge, GB)
Assignee: Nuclera Ltd
G01N33/542B01L3/502784G01N33/6803
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12699087
App. No.
18/021,945
Granted
Aug 4, 2026
Kind
B2
Abstract

Provided herein are methods, and compositions for the real-time detection of protein synthesis. The methods are applicable to monitoring on a microfluidic device.

Claims (22)

1 . A method for the monitoring of cell free protein synthesis in a droplet on a digital microfluidic device comprising:

a. cell free transcription and translation of a protein of interest fused to a peptide tag where the peptide tag is a component of a fluorescent protein; and

b. monitoring, in the digital microfluidic device, the presence of the peptide tag using a further polypeptide, said further polypeptide being a complementary portion of the fluorescent protein, which in the presence of the peptide tag produces a detectable signal; wherein the droplets are in an oil layer and the oil layer contains surfactant.

2 . The method as claimed in claim 1 , wherein the transcription and translation occurs in human lysate system.

3 . The method as claimed in claim 1 , wherein the transcription and translation occurs in a rabbit reticulocyte lysate (RRL) system or a Chinese Hamster Ovary lysate system.

4 . The method as claimed in claim 1 , wherein the cell free transcription and translation occurs in a wheat germ cell-free system.

5 . The method as claimed in claim 1 , wherein herein the cell free transcription and translation occurs a E. coli whole cell lysate system.

6 . The method as claimed in claim 1 , wherein the cell free transcription and translation occurs in a system of purified recombinant elements (PURE).

7 . The method as claimed in claim 1 , wherein the cell free transcription and translation are coupled.

8 . The method as claimed in claim 1 , wherein the cell free transcription and translation are uncoupled.

9 . The method as claimed in claim 1 , wherein the peptide tag is one component of a green fluorescent protein (GFP) or one component of sfCherry.

10 . The method as claimed in claim 9 wherein the peptide tag is GFP 11 and the further polypeptide is GFP 1-10 or wherein the peptide tag is sfCherry11 and the further polypeptide is sfCherry 1-10 .

11 . The method as claimed in claim 1 , wherein the protein of interest is fused to multiple peptide tags.

12 . The method as claimed in claim 11 wherein the protein of interest is fused to multiple GFP 11 peptide tags or multiple sfCherry 11 peptide tags.

13 . The method as claimed in claim 11 , wherein the protein of interest is fused to one or more sfCherry 11 peptide tags and one or more GFP 11 peptide tags.

14 . The method as claimed in claim 11 , wherein the multiple peptide tags are fused to the peptide of interest in a tandem fashion.

15 . The method as claimed in claim 1 , wherein the protein of interest is a single.

16 . The method as claimed in claim 15 , wherein the single protein of interest is a TdT, IFN beta 1-alpha, VEGF or is a protein part of a protein-protein complex or larger assembly.

17 . The method of claim 1 , wherein the surfactant in the oil layer is a non-ionic surfactant.

18 . The method according to claim 1 , wherein the surfactant is a sorbitan ester.

19 . The method according to claim 18 , wherein the surfactant is sorbitan trioleate.

20 . The method as claimed in claim 16 , wherein the protein of interest is a terminal deoxynucleotidyl transferase (TdT) enzyme or a truncated version thereof or the homologous amino acid sequence of a terminal deoxynucleotidyl transferase (TdT) enzyme in other species or the homologous amino acid sequence of Polμ, Polβ, Polλ, and Polθ of any species or the homologous amino acid sequence of X family polymerases of any species.